The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

Serina Therapeutics, Inc. ("Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug optimization technology, today congratulates its ...

A growth-focused fund blending momentum and strong earnings. High upside potential with elevated volatility. Best for ...

NEW YORK, June 16, 2025 /PRNewswire/ — According to a new comprehensive report from The Insight Partners, the global land ...

Chuck Magro, CEO of seed and pesticide giant Corteva, discusses the challenges facing farmers that his company is investing millions in to fight, the potentially transformative power of gene editing ...

The efforts of CNIC and CMIE are setting the stage for this future, ensuring that Canada remains at the cutting edge of ...

On June 10, 2025, the Commissioner of the FDA, Dr. Martin Makary, and Dr. Vinayak Prasad, the Director of the FDA’s Center ...

Genflow Biosciences Provides Half Year Corporate Update on SIRT6 Programs, IP Progress and Strategic Partnerships LONDON, UK / ACCESS Newswire / June 17, 2025 / Genflow Biosciences Plc ...

The metro's elected officials, stakeholders and academics weigh in on what Des Moines needs to do to stay on the right track.

A tul Butte, a biomedical informatician and pediatrician, passed away at age 55 following a long battle with cancer, ...